Target intelligence / Profile preview

Various drugs and toxins in the gastrointestinal tract

Molecular classification
Other
01

Overview

Various drugs and toxins in the gastrointestinal tract represent a broad category of exogenous substances rather than a specific endogenous molecular target like a receptor or enzyme. These substances include ingested poisons, drug overdoses, and metabolic byproducts that are targeted by adsorbents, chelators, or ion-exchange resins within the gut lumen. The primary therapeutic goal in targeting these substances is to prevent their absorption into the systemic circulation, thereby mitigating toxicity or managing systemic electrolyte imbalances (StatPearls: Activated Charcoal). For example, activated charcoal is a common intervention that utilizes its vast surface area to non-specifically adsorb a wide array of chemical moieties through van der Waals forces (StatPearls: Gastrointestinal Decontamination). Other agents, such as sevelamer or sodium polystyrene sulfonate, target specific ions like phosphate or potassium to treat chronic conditions like hyperphosphatemia in kidney disease (PubMed: PMID 29939625). Because this "target" is a heterogeneous collection of molecules with diverse chemical structures, it is considered a non-specific pharmacological target used primarily in emergency medicine and nephrology. Safety concerns associated with these interventions include gastrointestinal obstruction and the risk of pulmonary aspiration, particularly with charcoal. Additionally, these binders can interfere with the absorption of necessary therapeutic medications, requiring careful timing of administration (PubMed: PMID 30571001).

Other names
GI toxinsIngested poisonsLuminal drugsGastrointestinal toxicantsIntestinal adsorbates
02

Mechanism of action

Physical adsorption, chemical chelation, or ion exchange within the gastrointestinal lumen to inhibit systemic absorption.

03

Biological functions

Other
04

Disease associations

PoisoningDrug overdoseInfectionOther
05

Safety considerations

Aspiration pneumoniaGastrointestinal obstructionConstipationReduced bioavailability of co-administered medicationsElectrolyte imbalance
06

Interacting drugs

Activated charcoal

8 more in the full profile.

07

Biomarkers

Serum drug concentrationSerum phosphate levelsSerum potassium levelsClinical toxicology screen

Beyond the preview

Go deeper on Various drugs and toxins in the gastrointestinal tract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Various drugs and toxins in the gastrointestinal tract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call